174 results on '"Geissler, Edward K."'
Search Results
2. Ribavirin Improves NK Cell IFNγ Response During Sofosbuvir-based DAA Therapy in CV-infected Liver Transplant Recipients
3. Transplantation Direct: TTS eJournal Progress Update
4. Randomized Sirolimus-based Early Calcineurin Inhibitor Reduction in Liver Transplantation: Impact on Renal Function
5. Anti-BAFF Treatment Interferes With Humoral Responses in a Model of Renal Transplantation in Rats
6. Extended Pancreas Donor Program—The EXPAND Study: A Prospective Multicenter Trial Testing the Use of Pancreas Donors Older Than 50 Years
7. European Reflections on New Indications for Extracorporeal Photopheresis in Solid Organ Transplantation
8. Predicting Early Viral Control under DAA Therapy for Chronic HCV Using Pretreatment Immunological Markers
9. Early Enrichment and Restitution of the Peripheral Blood Treg Pool is Associated with Rejection-Free Stable Immunosuppression After Liver Transplantation
10. DHRS9 is a Stable Marker of Human Regulatory Macrophages
11. Generation of TIGIT+ iTregs by Human Regulatory Macrophages before Kidney Transplantation
12. BTNL8 is Expressed by Human Mreg-induced FOXP3+ iTregs
13. The Destiny of Articles When Pairing “Traditional”—With Open Access Sibling Journals
14. DHRS9 Is a Stable Marker of Human Regulatory Macrophages
15. Advancing Transplantation: New Questions, New Possibilities in Kidney and Liver Transplantation
16. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
17. Transplantation Reaches 100th Volume
18. COVID-19: A Year on
19. The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020
20. The Destiny of Articles When Pairing “Traditional”—With Open Access Sibling Journals
21. Can Mycophenolic Acid-based Immunosuppression Benefit Liver Transplant Patients With HCC?
22. The Authors’ Reply
23. Donor-specific Anti-HLA Antibodies Present in Pooled Human Serum Do Not Prevent Development of Human Mreg_UKR From Monocytes in Culture
24. Advancing Transplantation
25. The Authors’ Reply
26. Early Enrichment and Restitution of the Peripheral Blood Treg Pool Is Associated With Rejection-Free Stable Immunosuppression After Liver Transplantation
27. Calcineurin Inhibitor Free De Novo Immunosuppression in Liver Transplant Recipients With Pretransplant Renal Impairment
28. CD27low Natural Killer Cells Prolong Allograft Survival in Mice by Controlling Alloreactive CD8+ T Cells in a T-Bet–Dependent Manner
29. Establishment of a Global Virtual Laboratory for Transplantation
30. Message from the Editors
31. No Acceleration of UV-Induced Skin Carcinogenesis from Evenly Spread Dietary Intake of Cyclosporine in Contrast to Oral Bolus Dosages
32. A Color-Coded Reporter Model to Study the Effect of Immunosuppressants on CD8+ T-Cell Memory in Antitumor and Alloimmune Responses
33. Establishing Guidelines for Organ Donation Systems
34. Late Deaths: What Can We Learn?
35. Influence of Immunosuppressive Drugs on the Recurrence of Hepatocellular Carcinoma After Liver Transplantation: A Gap Between Basic Science and Clinical Evidence
36. Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
37. Mesenchymal Stem Cells Can Affect Solid Organ Allograft Survival
38. Mycophenolate Mofetil Inhibits Tumor Growth and Angiogenesis In Vitro but Has Variable Antitumor Effects In Vivo, Possibly Related to Bioavailability
39. Development of De Novo Cancer in p53 Knock-Out Mice is Dependent on the Type of Long-Term Immunosuppression Used
40. Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model
41. Caspase 3 Inhibition Improves Survival and Reduces Early Graft Injury After Ischemia and Reperfusion in Rat Liver Transplantation
42. PRO- AND ANTI-CANCER EFFECTS OF IMMUNOSUPPRESSIVE AGENTS USED IN ORGAN TRANSPLANTATION
43. RAPAMYCIN PROTECTS ALLOGRAFTS FROM REJECTION WHILE SIMULTANEOUSLY ATTACKING TUMORS IN IMMUNOSUPPRESSED MICE
44. THE ANTINEOPLASTIC DRUG PACLITAXEL HAS IMMUNOSUPPRESSIVE PROPERTIES THAT CAN EFFECTIVELY PROMOTE ALLOGRAFT SURVIVAL IN A RAT HEART TRANSPLANT MODEL1
45. Donor-specific Anti-HLA Antibodies Present in Pooled Human SerumDo Not Prevent Development of Human Mreg_UKR From Monocytes in Culture.
46. THE RELATIVE EXPRESSION OF MEMBRANE-BOUND VERSUS SOLUBLE MHC CLASS I ANTIGEN BY HEPATOCYTES DETERMINES THEIR IMMUNOSUPPRESSIVE POTENTIAL IN ORGAN TRANSPLANTATION.
47. SOLUBLE MHC CLASS I GENE THERAPY SUPPRESSES THE HUMORAL RESPONSE AND PREVENTS HYPERACUTE ALLOGRAFT REJECTION IN ACTIVELY SENSITIZED RECIPIENTS.
48. SPLENIC INJECTION OF GENETICALLY-MODIFIED AUTOLOGOUS HEPATOCYTES EXPRESSING SECRETED ALLO-MHC CLASS I ANTIGEN INCREASES CD8-CELL APOPTOSIS AND REDUCES ALLO-CTL ACTIVITY
49. SECRETED DONOR MHC ANTIGEN EXPRESSED AFTER GENE TRANSFER PREVENTS ACCELERATION OF LIVER ALLOGRAFT REJECTION INDUCED BY MEMBRANE-BOUND DONOR ANTIGEN
50. IN VIVO DELIVERY OF AUTOLOGOUS HEPATOCYTES TRANSFECTED TO EXPRESS SECRETED DONOR-MHC CLASS I ANTIGEN PREVENTS PASSIVE TRANSFER OF HYPERACUTE HEART ALLOGRAFT REJECTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.